165 related articles for article (PubMed ID: 31928345)
41. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
42. Environmental stress stability of pectin-stabilized resveratrol liposomes with different degree of esterification.
Shao P; Wang P; Niu B; Kang J
Int J Biol Macromol; 2018 Nov; 119():53-59. PubMed ID: 30036624
[TBL] [Abstract][Full Text] [Related]
43. pH-Dependent Behavior of Novel Gellan Beads Loaded with Naproxen.
Osmalek T; Froelich A; Milanowski B; Bialas M; Hyla K; Szybowicz M
Curr Drug Deliv; 2018; 15(1):52-63. PubMed ID: 28260506
[TBL] [Abstract][Full Text] [Related]
44. Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin-based formulation.
Das S; Ng KY
J Pharm Sci; 2010 Dec; 99(12):4903-16. PubMed ID: 20572052
[TBL] [Abstract][Full Text] [Related]
45. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
Joshi G; Kumar A; Sawant K
Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
[TBL] [Abstract][Full Text] [Related]
47. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.
Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z
AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441
[TBL] [Abstract][Full Text] [Related]
48. S-protected gellan gum: Decisive approach towards mucoadhesive antimicrobial vaginal films.
Jalil A; Asim MH; Le NN; Laffleur F; Matuszczak B; Tribus M; Bernkop-Schnürch A
Int J Biol Macromol; 2019 Jun; 130():148-157. PubMed ID: 30779984
[TBL] [Abstract][Full Text] [Related]
49. Development and optimization of sustained release mucoadhesive composite beads for colon targeting.
Kurra P; Narra K; Puttugunta SB; Kilaru NB; Mandava BR
Int J Biol Macromol; 2019 Oct; 139():320-331. PubMed ID: 31374273
[TBL] [Abstract][Full Text] [Related]
50. Intestinal enzyme delivery: Chitosan/tripolyphosphate nanoparticles providing a targeted release behind the mucus gel barrier.
Leichner C; Jelkmann M; Prüfert F; Laffleur F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2019 Nov; 144():125-131. PubMed ID: 31526841
[TBL] [Abstract][Full Text] [Related]
51. Nanoparticles prepared by polysaccharides extracted from Biyang floral mushroom loaded with resveratrol: Characterization, bioactivity and release behavior under in vitro digestion.
Liu K; Liu Y; Lu J; Liu X; Hao L; Yi J
Food Chem; 2023 Nov; 426():136612. PubMed ID: 37348397
[TBL] [Abstract][Full Text] [Related]
52. Spiral-Dextrin Complex Crystals: Efficient Approach for Colon-Targeted Resveratrol Delivery.
Wang PP; Luo ZG; Tamer TM
J Agric Food Chem; 2021 Jan; 69(1):474-482. PubMed ID: 33372794
[TBL] [Abstract][Full Text] [Related]
53. Enhanced oral permeability of Trans-Resveratrol using nanocochleates for boosting anticancer efficacy; in-vitro and ex-vivo appraisal.
El-Melegy MG; Eltaher HM; Gaballah A; El-Kamel AH
Eur J Pharm Biopharm; 2021 Nov; 168():166-183. PubMed ID: 34481049
[TBL] [Abstract][Full Text] [Related]
54. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.
Elsheikh MA; Elnaggar YSR; Otify DY; Abdallah OY
Pharm Res; 2018 Jan; 35(1):18. PubMed ID: 29305670
[TBL] [Abstract][Full Text] [Related]
55. Development of praziquantel-loaded PLGA nanoparticles and evaluation of intestinal permeation by the everted gut sac model.
Mainardes RM; Chaud MV; Gremião MP; Evangelista RC
J Nanosci Nanotechnol; 2006; 6(9-10):3057-61. PubMed ID: 17048518
[TBL] [Abstract][Full Text] [Related]
56. Formulation design, optimization and
Hasija R; Chaurasia S; Gupta S
Pharm Dev Technol; 2021 Nov; 26(9):953-966. PubMed ID: 34374616
[TBL] [Abstract][Full Text] [Related]
57. Heparin appended ADH-anionic polysaccharide nanoparticles for site-specific delivery of usnic acid.
Garg A; Garg S; Sahu NK; Rani S; Gupta U; Yadav AK
Int J Pharm; 2019 Feb; 557():238-253. PubMed ID: 30594688
[TBL] [Abstract][Full Text] [Related]
58. In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels.
Xavier M; García-Hevia L; Amado IR; Pastrana L; Gonçalves C
Int J Nanomedicine; 2019; 14():9077-9088. PubMed ID: 31819420
[TBL] [Abstract][Full Text] [Related]
59. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
Salunke SR; Patil SB
Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
[TBL] [Abstract][Full Text] [Related]
60. Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
Beloqui A; Solinís MÁ; des Rieux A; Préat V; Rodríguez-Gascón A
Int J Pharm; 2014 Jul; 468(1-2):105-11. PubMed ID: 24746410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
